ImmunityBio IBRX
NASDAQ IBRX
$8.64 -0.13 (-1.48%)
At close: Oct 21, 2026 · 4:00 PM EDT

ImmunityBio (IBRX) Short-Term Debt issuances (2026)

Updated

ImmunityBio (IBRX) recorded Short-Term Debt issuances of $61,000 in Q1 2026.

Analysis

ImmunityBio (IBRX) Short-Term Debt issuances (2026) Analysis & Trends

For FY2025, ImmunityBio reported Short-Term Debt issuances of $2.88 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Issuance (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 707.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 ImmunityBio 9.07 Bn 7.83 Bn 50.94 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 61,000.00
API Access

ImmunityBio Short-Term Debt issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-issuances&ticker=IBRX&period=max&api_key=YOUR_API_KEY